Search Results

Researchers at the Francis Crick Institute and King’s College London are joining forces with the Indian Institute of Science to explore how variations in the body’s initial immune defence and risk of cardiovascular disease affect COVID-19 outcomes for South Asian people living in the UK and in India. 

Scientists have been receiving help with vital coronavirus research from an unlikely team of data analysts - players of the popular online computer game, EVE Online. 

Patients with COVID-19 will be given the cystic fibrosis drug ‘Dornase alfa’ to determine if it can help improve survival by reducing excess inflammation in the lungs, as part of a trial co-led by UCL and the Francis Crick Institute.

DeepMind’s AlphaFold system has been used to produce structural predictions of understudied proteins of SARS-CoV-2, the virus that causes COVID-19.

Researchers from the Crick and Imperial College London have started work on a new study, funded by Kidney Research UK and the National Kidney Federation, to find out how effective COVID-19 vaccines are in people who go to hospital for dialysis treatment.

Researchers at the Francis Crick Institute and the National Institute for Health and Care Research Biomedical Research Centre at UCLH have highlighted the importance of continued surveillance of emerging SARS-CoV-2 variants and vaccine performance as the virus continues to evolve.

Researchers at the Francis Crick Institute, UCL and UCLH have embarked on a new study to understand more about how and why people are vulnerable to infection with SARS-CoV-2.

Having systems in place to keep track of new and existing infectious diseases has always been an important aspect of human health. The onset of the COVID-19 pandemic meant that we needed a whole new set of processes to deal with pandemic surveillance.

Researchers at the Crick and Charité – Universitätsmedizin Berlin have developed a new technology that measures the human proteome quickly and at a low cost. They hope this tech will lead to more effective drug screening and biomarker discovery. Image: Arne Sattler/Charité

Katie Bentley's group are working with NHSx to model how Covid-19 spreads within hospitals and communities. We caught up with Katie to find out more about it.